• Vice President, Partners Harvard Medical International
• Affiliate Pathologist, Massachusetts General Hospital
• Associate Professor of Pathology, Harvard Medical School

Dr. Aretz is a member of the PHMI's senior management team focusing largely on academic programs and institutions, such as universities, medical schools and academic medical centers.

A native of Germany, Dr. Aretz has been in the academic practice of cardiovascular pathology since 1981. He was the course director of a major integrated medical school course at Harvard from 1992 to 2005. He is a Program Director for the Harvard Macy Institute, and has been involved in international programs since 1996. He holds a clinical appointment at the Massachusetts General Hospital (MGH), where he completed his post-doctoral training. He has served on many academic and hospital (IRB chairman) committees and industrial boards, and is the co-founder of three medical technology companies. He received his medical degree from Harvard Medical School and is certified in anatomic and clinical pathology by the American Board of Pathology.

Dr. Aretz has lectured and published extensively and has received multiple teaching awards at Harvard Medical School and MGH. He has also won recognition for his efforts to improve medical education around the world through intra-institutional collaborations. In 2006 he was named an "Ehrenbürger" (honorary citizen) of the Ludwig Maximilians University in Munich for his contributions to the long-standing PHMI-LMU alliance. Recently he was recognized with a MILES Award (Mentoring, Innovation, and Leadership in Educational Scholarship), given by the Yong Loo Lin School of Medicine at the National University of Singapore for outstanding contributions to the advancement of global medical education and academic medicine.

• Thurer R, Aretz HT, Wilkins ML, Younis S, Bishawi AH, Eckhert NL, Armstrong E, Makadon H, Mitchell JD. Facility Design to Support Educational Innovation in a Unique Healthcare Environment. Harvard Medical School Dubai Center Institute for Postgraduate Education and Research and Harvard Medical International.
  
  

• Jang IK, Tearney GJ, MacNeill B, Takano M, Moselewski F, Iftima N, Shishkov M, Houser S, Aretz HT, Halpern EF, Bouma BE. In vivo characterization of coronary atherosclerotic plaque by use of optical coherence tomography. Circulation. 2005; 111:1551-5.
  
  
• MacNeill BD, Jang I-K, Bouma BE, Iftimia N, Takano M, Yabushita H, Shishkov M, Kauffman CR, Houser SL, Aretz HT DeJoseph D, Halpern EF, Tearney GJ. Focal and multi-focal plaque macrophage distributions in patients with acute and stable presentations of coronary artery disease. J Am Coll Cardiol 2004;44:972-979.
  
  
• Tearney GJ, MacNeill B, Jang IK, Ifitimia N, Shishkov M, Houser SL, Aretz HT, Halpern EF, Bouma BE. Coronary plaque macrophage distributions in living patients measured by optical coherence tomography. In: SPIE Conference Photonoics West '04; 2004: paper 5316-11.
  
  

• Aretz HT. Problem-based learning -- Is it relevant to clinical education? Medizinische Ausbildung 2003;20:186-193
  
  
• Aretz HT. Diagnostic Surgical Pathology, 4th edition. Raven Press, NY, NY. 2003
  
  
• Hassink RJ, Aretz HT, Ruskin J, Keane D. Morphology of atrial myocardium in human pulmonary veins: a postmortem analysis in patients with and without atrial fibrillation. J Am Coll Cardiol. 2003;42:1108-1114
  
  
• Ichinose F, Bloch KD, Wu JC, Hataishi R, Aretz HT, Picard MH, Scherrer-Crosbie M. Pressure overload-induced LV hypertrophy and dysfunction in mice are exacerbated by congenital NOS3 deficiency. Am J Physiol Heart Circ Physiol. 2004;286:H1070-1075.
  
  
• MacNeill B, Jang IK, Bouma BE, Yabushita H, Houser SL, Aretz HT, Jang IK, Schlendorf K, Kauffman CR, Shishkov M, Iftimia N., Halpern EF, Tearney GJ. Focal and multi-focal plaque macrophage distributions in patients with acute and stable presentations of coronary artery disease. Journal of American College of Cardiology 2004; accepted for publication.
  
  
• Pagani FD, DerSimonian H, Zawadzka A, Wetzel K, Edge AB, Jacoby DB, Dinsmore JH, Wright S, Aretz HT, Eisen HJ, Aaronson KD. Autologous skeletal myoblasts transplanted to ischemia-damaged myocardium in humans. Histological analysis of cell survival and differentiation. J Am Coll Cardiol 2003;41:879-888
  
  
• Planz B, Tabatabaei S, Kirley SD, Aretz HT, Wang Q, Lin CW, McDougal WS, Marberger M. Studies on the differentiation pathway and growth characteristics of epithelial culture cells of the human prostate. Prostate Cancer Prostatic Dis. 2004;7:73-83
  
  
• Rubenstein MH, Finn AV, Leinbach RC, Hollenbach S, Aretz HT, Virmani R, Gold HK. Short-term intravenous eptifibatide infusion combined with reduced dose recombinant tissue plasminogen activator inhibits platelet recruitment at sites of coronary artery injury. J Am Coll Cardiol. 2004;43:287-294.